HPLC purity ≥ 99%
Janoshik CoA per batch
Stable lyophilised storage
Dispatched within 24 h from the EU
Research reagents — RUO
Full batch number traceability
Secure & discreet payment
HPLC purity ≥ 99%
Janoshik CoA per batch
Stable lyophilised storage
Dispatched within 24 h from the EU
Research reagents — RUO
Full batch number traceability
Secure & discreet payment
HPLC purity ≥ 99%
Janoshik CoA per batch
Stable lyophilised storage
Dispatched within 24 h from the EU
Research reagents — RUO
Full batch number traceability
Secure & discreet payment
HPLC purity ≥ 99%
Janoshik CoA per batch
Stable lyophilised storage
Dispatched within 24 h from the EU
Research reagents — RUO
Full batch number traceability
Secure & discreet payment
← Notebook
Science· 6 min read

SNAP-8: a mimetic octapeptide studied for its competition with the SNARE complex

By mimicking a fragment of the SNAP-25 protein, this synthetic peptide is studied for its interference with calcium-dependent neuronal exocytosis.

SNAP-8 is a synthetic octapeptide designed as a mimetic of the N-terminal domain of the SNAP-25 protein — an essential component of the molecular machinery that regulates neurotransmitter release.

The SNARE complex: a vesicular fusion mechanism

The SNARE complex (Soluble NSF Attachment protein REceptor) is the molecular machinery responsible for the fusion of synaptic vesicles with the presynaptic membrane — the final step of neurotransmitter release. SNAP-25 is one of the three constituent proteins of this complex, alongside syntaxin and synaptobrevin.

Partial competition with endogenous SNAP-25

In vitro studies (PMID 16641057) describe a partial competition of SNAP-8 with endogenous SNAP-25 for the formation of the SNARE complex. By occupying some of the interaction sites normally used by native SNAP-25, the peptide reduces the functional formation of the complex and attenuates calcium-dependent neurotransmitter release in the models studied.

A local effect, with no reported systemic diffusion

At the cutaneous level, preclinical models report a transient reduction in facial muscle contractions — a local myorelaxant effect attributed to interference with neurotransmitter exocytosis at the neuromuscular junction. The literature emphasizes the absence of documented systemic diffusion for this localized mechanism of action.

No reported hormonal effect

Unlike many research peptides studied in this catalog, no systemic hormonal effect has been documented for SNAP-8 — consistent with its strictly local mechanism of action on the synaptic exocytosis machinery.

A mimetic among other approaches to the neuromuscular junction

SNAP-8 illustrates a pharmacological approach based on structural mimicry: reproducing a functional fragment of a native protein to selectively interfere with its mechanism, a strategy also found in the design of other research peptides studied for their localized specificity of action.

To learn more